BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37964265)

  • 1. Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic pulmonary fibrosis.
    Karampitsakos T; Galaris A; Chrysikos S; Papaioannou O; Vamvakaris I; Barbayianni I; Kanellopoulou P; Grammenoudi S; Anagnostopoulos N; Stratakos G; Katsaras M; Sampsonas F; Dimakou K; Manali ED; Papiris S; Tourki B; Juan-Guardela BM; Bakakos P; Bouros D; Herazo-Maya JD; Aidinis V; Tzouvelekis A
    Respir Res; 2023 Nov; 24(1):279. PubMed ID: 37964265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-L1 mediates lung fibroblast to myofibroblast transition through Smad3 and β-catenin signaling pathways.
    Guo X; Sunil C; Adeyanju O; Parker A; Huang S; Ikebe M; Tucker TA; Idell S; Qian G
    Sci Rep; 2022 Feb; 12(1):3053. PubMed ID: 35197539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of PD-1/PD-L1 axis in idiopathic pulmonary fibrosis: Friend or foe?
    Jiang A; Liu N; Wang J; Zheng X; Ren M; Zhang W; Yao Y
    Front Immunol; 2022; 13():1022228. PubMed ID: 36544757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-8 concurrently promotes idiopathic pulmonary fibrosis mesenchymal progenitor cell senescence and PD-L1 expression enabling escape from immune cell surveillance.
    Yang L; Xia H; Gilbertsen A; Smith K; Racila E; Bitterman PB; Henke CA
    Am J Physiol Lung Cell Mol Physiol; 2023 Jun; 324(6):L849-L862. PubMed ID: 37121574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Bruton's tyrosine kinase in B-cells and autoreactive IgA in patients with idiopathic pulmonary fibrosis.
    Heukels P; van Hulst JAC; van Nimwegen M; Boorsma CE; Melgert BN; von der Thusen JH; van den Blink B; Hoek RAS; Miedema JR; Neys SFH; Corneth OBJ; Hendriks RW; Wijsenbeek MS; Kool M
    Respir Res; 2019 Oct; 20(1):232. PubMed ID: 31651327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-L1 upregulation promotes drug-induced pulmonary fibrosis by inhibiting vimentin degradation.
    Li Q; Deng MS; Wang RT; Luo H; Luo YY; Zhang DD; Chen KJ; Cao XF; Yang GM; Zhao TM; Xu B; Xu CX; Wang JM
    Pharmacol Res; 2023 Jan; 187():106636. PubMed ID: 36586643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
    Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
    Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of
    Erber R; Stöhr R; Herlein S; Giedl C; Rieker RJ; Fuchs F; Ficker JH; Hartmann A; Veltrup E; Wirtz RM; Brueckl WM
    Anticancer Res; 2017 Dec; 37(12):6771-6778. PubMed ID: 29187455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediastinal lymph node enlargement in idiopathic pulmonary fibrosis: relationships with disease progression and pulmonary function trends.
    Sgalla G; Larici AR; Golfi N; Calvello M; Farchione A; Del Ciello A; Varone F; Iovene B; Manfredi R; Richeldi L
    BMC Pulm Med; 2020 Sep; 20(1):249. PubMed ID: 32957969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
    Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
    Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration to assess tumor-programmed cell death ligand-1 expression in mediastinal lymph nodes metastasized from non-small cell lung cancer.
    Mineura K; Hamaji M; Yoshizawa A; Nakajima N; Kayawake H; Tanaka S; Yamada Y; Yutaka Y; Nakajima D; Ohsumi A; Menju T; Chen-Yoshikawa TF; Date H
    Surg Today; 2020 Sep; 50(9):1049-1055. PubMed ID: 32166496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitor of PD-1/PD-L1: a new approach may be beneficial for the treatment of idiopathic pulmonary fibrosis.
    Tan J; Xue Q; Hu X; Yang J
    J Transl Med; 2024 Jan; 22(1):95. PubMed ID: 38263193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis.
    Geng Y; Liu X; Liang J; Habiel DM; Kulur V; Coelho AL; Deng N; Xie T; Wang Y; Liu N; Huang G; Kurkciyan A; Liu Z; Tang J; Hogaboam CM; Jiang D; Noble PW
    JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30763282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis.
    Vittal R; Mickler EA; Fisher AJ; Zhang C; Rothhaar K; Gu H; Brown KM; Emtiazjoo A; Lott JM; Frye SB; Smith GN; Sandusky GE; Cummings OW; Wilkes DS
    PLoS One; 2013; 8(10):e76451. PubMed ID: 24204629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1 up-regulation on CD4
    Celada LJ; Kropski JA; Herazo-Maya JD; Luo W; Creecy A; Abad AT; Chioma OS; Lee G; Hassell NE; Shaginurova GI; Wang Y; Johnson JE; Kerrigan A; Mason WR; Baughman RP; Ayers GD; Bernard GR; Culver DA; Montgomery CG; Maher TM; Molyneaux PL; Noth I; Mutsaers SE; Prele CM; Peebles RS; Newcomb DC; Kaminski N; Blackwell TS; Van Kaer L; Drake WP
    Sci Transl Med; 2018 Sep; 10(460):. PubMed ID: 30257954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glutamine transporter ASCT2 mitigates bleomycin-induced pulmonary fibrosis in mice.
    Lian N; Jin H; Zhu W; Zhang C; Qi Y; Jiang M; Mao J; Lu X; Zhao F; Xi B; Qi X; Li Y
    Acta Histochem; 2022 Dec; 124(8):151961. PubMed ID: 36265204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the molecular mechanisms of Maxing Huoqiao Decoction in treating pulmonary fibrosis via transcriptional profiling and circRNA-miRNA-mRNA network analysis.
    Zhao C; Bu E; Zhang C; Lai R; He J; Guo B; Guo W; Liu L; Pan H
    Phytomedicine; 2023 Jul; 115():154754. PubMed ID: 37087790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma.
    Gao Y; Li S; Xu D; Chen S; Cai Y; Jiang W; Zhang X; Sun J; Wang K; Chang B; Wang F; Hong M
    Chin J Cancer; 2017 Jul; 36(1):61. PubMed ID: 28754154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IL-33:ST2 axis is unlikely to play a central fibrogenic role in idiopathic pulmonary fibrosis.
    Stephenson KE; Porte J; Kelly A; Wallace WA; Huntington CE; Overed-Sayer CL; Cohen ES; Jenkins RG; John AE
    Respir Res; 2023 Mar; 24(1):89. PubMed ID: 36949463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.